venlafaxine, and dopamine blocking agents (promethazine, metoclopramide, and prochlorperazine). [9] There is no published reports on donepezil causing PAMS/PLMS/RLS. [10] Although PAMS is closely related to PLMS and RLS, it is not yet clear if it shares the same pathophysiology. However, there are reports of patients with spinal cord transaction presenting with PLMS and PAMS, indicating that motor programs for both these phenomena exist at the level of the neuraxis. [3] The dopaminergic system is thought to play a major role in the pathogenesis of PLMS, and dopaminergic antagonists are found to induce PLMS. [4] Furthermore, serotonergically mediated dopaminergic inhibition was thought to be the mechanism by which SSRIs and SNRIs induce PLMS. [3] Both antidopaminergic and serotonergic activities of quetiapine might have induced PAMS in our case.
The major limitation of this case report is that none of the differential diagnoses discussed could be objectively confirmed by an overnight PSG examination as the symptoms resolved soon after stopping the drug quetiapine.
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Commentary on "high-risk behavior in patients with alcohol dependence"
Sir, I read with interest the study on high-risk behavior in patients with alcohol dependence by Korlakunta and Reddy [1] in March-April issue of 2019. The study used the high-risk behavior questionnaire to estimate the rate of such behavior in patients with alcohol dependence. It was found that 120/200 (60%) patients had one high-risk behavior associated with alcohol use. The conclusion from the study was that "the occurrence of high-risk behavior was substantial among patients with alcohol dependence syndrome." Furthermore, several demographic and clinical factors were shown to be associated with high-risk behaviors. However, there are several glaring errors in the manuscript.
The objective of the study was mentioned as "to assess the relationship between high-risk behavior and alcohol dependence." In the absence of a control group in the current study, concluding such a relationship is not possible. The period for the assessment is not clearly stated. Assuming the occurrence of such behavior any time during their drinking career, it is difficult to fathom that each of 120 individuals had only one high-risk behavior. More likely, there would be multiple such behaviors in an individual subject; the recall of such events, however, could be a source of bias. Surprisingly, there is no mention of the eligibility criteria of the study participants, except for International Classification of Disease-10 criteria of alcohol dependence syndrome.
The manuscript mentions the use of "Pearson's correlation coefficient, t-test, and logistic regression" under the methods section. However, the only analysis that is reported in the original manuscript is the "chi-square test" in Tables  3 to 5 . Furthermore, the Chi-square test has been used for variables where cells are empty, which is a violation of assumption for the test. One of the assumptions states that the expected frequency in the cell should be five or more in at least 80% of the cells, and no cell should have an expected count of <1. [2] If the assumption is violated, an alternate test such as Fisher's exact test should be performed. [2] The researchers have created meaningless categories out of continuous variables such as age, age at initiation of drink, age at dependence, and duration of dependence, which limits interpretability. Specifically, such categorization leads to loss of power in detecting associations and residual confounding, hence, better avoided. [3] Multiple hypothesis testing was carried out without any corrections, which could inflate the family-wise error rate. Reporting of confidence interval could have been more meaningful.
Several other minor errors in reporting could have been avoided. For example, "P = 0.000" should be mentioned as "P < 0.001," as P value can never be zero. Uniform use of three digits after decimal points for P values and two digits after decimal points for the rest of data would enhance readability.
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Factors influencing treatment outcome in bipolar disorder
Sir,
We have read with great interest the paper titled, "Identification of factors affecting treatment outcome in bipolar disorder" by Vedanarayanan et al. [1] published recently in your journal. The article becomes timely when there is accruing research in the field of bipolar disorder (BD) course and outcome in our region. [2, 3] Identification of factors influencing treatment outcomes is a step ahead in enhancing the recovery and functioning of a patient suffering from BD.
While the paper deserves merit for incorporating a longitudinal study design in analyzing factors influencing treatment outcome, certain aspects of the paper need to be analyzed critically to replicate and expand the current research. The authors have included BD patients of various types (BD-I, BD-II, with mixed features and cyclothymia), who were in clinical remission during enrolment into the study, and assessed the improvement in clinical symptoms after 6 months from the index visit. The authors' efforts in defining early onset and treatment delay in BD were quite informative in this paper.
